S Esquenazi, C L Fry, E Holley. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, TopicalAgedAntineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useBiopsy, NeedleCarcinoma in Situ/drug therapyCarcinoma in Situ/pathologyCarcinoma, Squamous Cell/drug therapyCarcinoma, Squamous Cell/pathologyConjunctival Neoplasms/drug therapyConjunctival Neoplasms/pathologyHumansInterferon alpha-2Interferon-alpha/administration & dosageInterferon-alpha/therapeutic useMaleRecombinant Proteins
Substances: See more » Antineoplastic AgentsInterferon alpha-2Interferon-alphaRecombinant Proteins
Year: 2005 PMID: 16113387 PMCID: PMC1772848 DOI: 10.1136/bjo.2004.063339
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638